Parnassus Investments

The Life Sciences Tools & Services sector could be poised for long-term growth as the complexity of drug development expands. We believe companies like Danaher and Thermo Fisher Scientific are well-positioned to thrive with their mission-critical products and strong management teams. Discover the key trends driving this sector’s recovery. https://bit.ly/4eg8hJs #Innovation #StockMarket

While the economy shows strength, we must remain vigilant on slower job creation and rising unemployment. Dive deeper into these trends and their implications for the market in our latest CIO Outlook. https://lnkd.in/gr_fxpek #StockMarket #MarketOutlook

Since we pledged to achieve net zero carbon emissions across our fund portfolio by 2050, we've made significant progress on our commitment. Learn more about this and other areas of engagement in our Annual Sustainability & Stewardship Report, available now. https://lnkd.in/gFawrZDR #Sustainability #ClimateChange

In our latest Parnassus View, we look at how the Life Sciences Tools & Services sector may be poised to bounce back over the next 12-18 months. We believe that leading companies like DHR and TMO are positioned to expand margins and make strategic acquisitions, benefiting from the industry's expected recovery. https://lnkd.in/gccaPi9W #Innovation #StockMarket

The Parnassus Core Equity Fund quarterly webinar is now available. Watch to get the latest Q3 updates from portfolio managers Todd Ahlsten, Ben Allen and Andrew Choi. https://lnkd.in/gnh6D_qM #Investing #ActiveManagement

From record-breaking pole vaults to market peaks, our CIO draws parallels between Olympic feats and economic triumphs. Dive into our latest analysis on AI, market risks and election implications. Read our latest CIO Outlook here: https://bit.ly/4eVCI8a #StockMarket #ActiveInvesting

Missed our recent Sustainability and Stewardship webinar? The replay is now available! Get insights on sustainable investments, portfolio outcomes, and key topics like climate risks and responsible AI. Watch it here now! https://bit.ly/4gTBhZV #Sustainability

In the world of investing, setbacks like earnings misses or delayed product launches often signal opportunity. In this Wall Street Transcript article, Billy Hwan, CPA, CFA touches on identifying those rare instances where the market may have overreacted. By pinpointing temporary challenges, they can take a contrarian view and invest for the long term, positioning themselves to benefit from the rebound. Read on to discover the key attributes of the Value Equity Fund and its attractive holdings. https://bit.ly/3NbDX7s #StockMarket #ValueStocks #Investing

The quarterly portfolio updates for the following funds are now available. - Parnassus Growth Equity Fund - Parnassus Value Equity Fund - Parnassus Mid Cap Fund - Parnassus Mid Cap Growth Fund - Parnassus Fixed Income Fund Hear our portfolio managers share their Q3 updates and their outlook for the rest of the year. Listen here: https://bit.ly/4f508ZH #Investing #StockMarket

Life Sciences Tools & Services companies are the unsung heroes of biopharma innovation. Our latest Parnassus View examines why, as cyclical headwinds subside, we believe these companies are poised for a strong recovery and sustained growth. Learn how leaders like Danaher and Thermo Fisher are positioned to potentially benefit from the rebound. https://bit.ly/4dGgEO6 #Investing #Innovation #StockMarket